End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.82 CNY | +1.49% | +9.42% | -34.03% |
Business Summary
Number of employees: 1,346
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Technical Services
64.9
%
| 319 | 46.8 % | 391 | 64.9 % | +22.32% |
Biopharmaceutical
26.2
%
| 159 | 23.2 % | 158 | 26.2 % | -0.59% |
Pharmaceutical Intermediate Production and Sales
8.1
%
| 201 | 29.4 % | 49 | 8.1 % | -75.69% |
In Vitro Diagnostics Reagent
0.8
%
| 4 | 0.6 % | 5 | 0.8 % | +20.69% |
Other
0.1
%
| 0 | 0.0 % | 0 | 0.1 % | +354.39% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 684 | 99.4 % | 602 | 100.0 % | -12.02% |
Foreign
0.0
%
| 4 | 0.6 % | 0 | 0.0 % | -98.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ya Chen
CEO | Chief Executive Officer | 52 | 04-11-16 |
Huang Chen
CHM | Chairman | 49 | 99-12-31 |
Han Zhen Xia
DFI | Director of Finance/CFO | 61 | 99-12-31 |
Jing Du
BRD | Director/Board Member | 40 | 02-12-31 |
Hua Dong Tang
BRD | Director/Board Member | 46 | 01-12-31 |
Kun Yang
IRC | Investor Relations Contact | - | - |
Sheng Qiang Li
PRN | Corporate Officer/Principal | 48 | 99-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Han Zhen Xia
DFI | Director of Finance/CFO | 61 | 99-12-31 |
Sheng Qiang Li
PRN | Corporate Officer/Principal | 48 | 99-12-31 |
Ya Chen
CEO | Chief Executive Officer | 52 | 04-11-16 |
Jia Feng Zhu
BRD | Director/Board Member | 55 | 15-09-27 |
Hua Dong Tang
BRD | Director/Board Member | 46 | 01-12-31 |
Ming Dong Ran
BRD | Director/Board Member | 49 | 21-01-21 |
Jie Yan
BRD | Director/Board Member | 59 | 18-12-11 |
Jing Du
BRD | Director/Board Member | 40 | 02-12-31 |
Man Qi Zhao
CHM | Chairman | 50 | 23-05-15 |
Hai Bing Zhou
BRD | Director/Board Member | 54 | 23-05-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 130,894,391 | 63,233,556 ( 48.31 %) | 0 | 48.31 % |
Company contact information
Wuhan Hiteck Biological Pharma Co., Ltd.
Hiteck Science & Technology Park Economic & Technological Dev Zone
430056, Wuhan
+
http://www.hiteck.com.cnSector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.03% | 430M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 300683 Stock
- Company Wuhan Hiteck Biological Pharma Co.,Ltd